EN | TR
E-ISSN: 1307-5608
Drug-Drug Interaction Management in Hepatitis C Treatment
PDF
Cite
Share
Request
Case Report
VOLUME: 71 ISSUE: 2
P: 174-176
August 2018

Drug-Drug Interaction Management in Hepatitis C Treatment

J Ankara Univ Fac Med 2018;71(2):174-176
DOI: 10.4274/atfm.54264
İrem Akdemir Kalkan 1
Güle Çınar 1
Mustafa Kemal Çelen 2
K. Osman Memikoğlu 1
1. Ankara Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Ankara, Türkiye
2. Dicle Üniversitesi Tıp Fakültesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Diyarbakır, Türkiye
No information available.
No information available
Received Date: 26.03.2018
Accepted Date: 25.07.2018
Publish Date: 10.10.2018
PDF
Cite
Share
Request

ABSTRACT

“Direct acting antivirals” cure over 99% in the course of the disease as a recent breakthrough treatment method in hepatitis C treatment. Possible drug-drug interactions should not be overlooked. In this case report we aimed to share how we managed the interaction in a patient who was planned to use sofosbuvir-ledipasvir. The use of direct antiviral drugs is a very important point in Hepatitis C treatment. A good patient history and a multidisciplinary approach are necessary for the interaction of drugs. These are necessary for successful and safe treatment of hepatitis C.

Keywords: Antiviral Treatment, Hepatitis C, Drug-drug Interactions

References

1
Initial Treatment of HCV Infection | HCV Guidance [Internet]. [cited 2018 Mar 12]. Available from: https://www.hcvguidelines.org/treatment-naive
2
Aygen B, Üniversitesi E, Fakültesi T, et al. Kronik Hepatit C Virusu İnfeksiyonunun Yönetimi: Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Viral Hepatit Çalışma Grubu Uzlaşı Raporu-2017 Güncellemesi. [cited 2018 Mar 12]; Available from: http://www.klimikdergisi.org/sayilar/104/buyuk/2-362.pdf
3
Carbamazepine Level: Reference Range, Interpretation, Collection and Panels [Internet]. [cited 2018 Mar 12]. Available from: https://emedicine.medscape.com/article/2089796-overview
4
Aşcı Songül Özkula Süleyman Demirel Üniversitesi H, Fakultesi T, Yazışma Adresi I, Doç Halil Aşcı Y. Terapötik indeksi dar olan ilaçlarda etkileşimler Drug interactions with narrow therapeutic index. [cited 2018 Mar 12]; Available from: http://dergipark.gov.tr/download/article-file/227753
5
Liverpool HEP Interactions [Internet]. [cited 2018 Mar 12]. Available from: https://www.hep-druginteractions.org/
6
Talavera Pons S, Boyer A, Lamblin G, et al. Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C. Br J Clin Pharmacol [Internet]. 2017 Feb 1 [cited 2018 Mar 12];83(2):269–93. Available from: http://doi.wiley.com/10.1111/bcp.13095
7
Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother [Internet]. 2003 Jun 12 [cited 2018 Mar 21];52(1):1–1. Available from: https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dkg301
2024 ©️ Galenos Publishing House